Kristin H. Karner, MD

Journal Article

1. Karner KH, George TI, Patel JL ().

   Current Aspects of Clonal Hematopoeisis: Implications for Clinical Diagnosis

   . Annals of Laboratory Medicine, 39(6), 509-514.
2. Karner KH, Menon MP, Inamdar KV, Carey JL (). Post-transplant CD4+ non-cytotoxic γδ T cell lymphoma with lymph node involvement. Journal of Hematopathology, 11(4), 107-113.
3. Karner KH, Inamdar KV (). Plasma cell myeloma mimicking classical Hodgkin lymphoma in the bone marrow. Int J Hematol, 107(2), 127-128.
4. Kezlarian B, Alhyari M, Venkataraman G, Karner K, Inamdar KV, Menon MP (). GATA3 immunohistochemical staining in Hodgkin lymphoma: Diagnostic utility in differentiating classic Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and other mimicking entities. Appl Immunohistochem Mol Morphol.
5. Gomez-Gelvez JC, Kryvenko ON, Chabot-Richards DS, Foucar K, Inamdar KV, Karner KH (2015 Jul). Comparative Analysis Reveals Potential Utility of Digital Microscopy in the Evaluation of Peripheral Blood Smears With Some Barriers to Implementation. Am J Clin Pathol, 144(1), 68-77.
6. Hunt KE, Salama ME, Sever CE, Foucar K (2013 Jul). Bone marrow examination for unexplained cytopenias reveals nonspecific findings in patients with collagen vascular disease. Arch Pathol Lab Med, 137(7), 948-54.
7. Chabot-Richards DS, Martin DR, Myers OB, Czuchlewski DR, Hunt KE (2011 Dec). Quantitative image analysis in the assessment of diffuse large B-cell lymphoma. Mod Pathol, 24(12), 1598-605.
8. Hunt KE, Hall B, Reichard KK (2010 Mar). Translocations involving MUM1 are rare in diffuse large B-cell lymphoma. Appl Immunohistochem Mol Morphol, 18(2), 109-12.
9. Garcia CF, Hunt KE, Kang H, Babb A, Gale JM, Vasef MA, Reichard KK (2010 Mar). Most morphologic features in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not reliably predict underlying FISH genetics or immunoglobulin heavy chain variable region somatic mutational status. Appl Immunohistochem Mol Morphol, 18(2), 119-27.
10. Mathew P, Simon TL, Hunt KE, Crookston KP (2007 Jan). How we manage requests for recombinant factor VIIa (NovoSeven). Transfusion, 47(1), 8-14.
11. Hunt K, Crookston KP, Simon TL (). Plasma Derivatives and Hemophilia Treatment: Emergence of recombinant factor VIIa as a treatment for inhibitors. Check Sample.
12. Castro E, Ogburn CE, Hunt KE, Tilvis R, Louhija J, Penttinen R, Erkkola R, Panduro A, Riestra R, Piussan C, Deeb SS, Wang L, Edland SD, Martin GM, Oshima J (1999 Feb 19). Polymorphisms at the Werner locus: I. Newly identified polymorphisms, ethnic variability of 1367Cys/Arg, and its stability in a population of Finnish centenarians. Am J Med Genet, 82(5), 399-403.
13. Wang L, Hunt KE, Martin GM, Oshima J (1998 Aug 01). Structure and function of the human Werner syndrome gene promoter: evidence for transcriptional modulation. Nucleic Acids Res, 26(15), 3480-5.
14. Ogburn CE, Oshima J, Poot M, Chen R, Hunt KE, Gollahon KA, Rabinovitch PS, Martin GM (1997 Dec). An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum Genet, 101(2), 121-5.
15. Karner KH, Menon MP, Inamdar KV, Carey JL (). Post transplant CD4+ non-cytotoxic gamma delta T-cell lymphoma with lymph node involvement. Journal of Hematopathology.
16. Karner KH, Kohan JL, Tripp SR, Salama ME (). Characterization of myeloid malignancies with TP53 mutations and comparison to P53 expression by immunohistochemical staining methods. Int J Lab Hematol.

Review

1. Hunt KE, Reichard KK, Wilson CS (2008 Jul). Mantle cell lymphoma lacking the t(11;14) translocation: a case report and brief review of the literature. [Review]. J Clin Pathol, 61(7), 869-70.
2. Hunt KE, Reichard KK (2008 Jan). Diffuse large B-cell lymphoma. [Review]. Arch Pathol Lab Med, 132(1), 118-24.

Book Chapter

1. Karner KH (). Sickle Cell Anemia. In Foucar K (Ed.), Diagnostic Pathology: Blood and Bone Marrow (2nd ed.). Philiadelphia: Elsevier.
2. Karner KH (). Paroxysmal Nocturnal Hemoglobinuria. In Foucar K (Ed.), Diagnostic Pathology: Blood and Bone Marrow (2nd ed.). Philadelphia: Elsevier.
3. Karner KH (). Pure Erythroid Leukemia (AML, NOS). In Foucar K (Ed.), Diagnostic Pathology: Blood and Bone Marrow (2nd ed.). Philadelphia: Elsevier.
4. Karner KH (). Thalassemia. In Foucar K (Ed.), Diagnostic Pathology: Blood and Bone Marrow (2nd ed.). Philadelphia: Elsevier.
5. Karner KH (). Acute Monoblastic and Monocytic Leukemia (AML, NOS). In Foucar K (Ed.), Diagnostic Pathology: Blood and Bone Marrow (2nd ed.). Philadelphia: Elsevier.
6. Karner KH (). Megaloblastic Anemia. In Foucar K (Ed.), Diagnostic Pathology: Blood and Bone Marrow (2nd ed). Philadelphia: Elsevier.
7. Karner KH (). Thrombocytosis. In Foucar K (Ed.), Diagnostic Pathology: Blood and Bone Marrow (2nd ed.). Philadelphia: Elsevier.
8. Karner KH (). Hemolytic Uremic Syndrome. In Foucar K (Ed.), Diagnostic Pathology: Blood and Bone Marrow (2017). Philadelphia: Elsevier.
9. Karner KH (). Hematologic Manifestations of Collagen Vascular Disorders. In Foucar K (Ed.), Diagnostic Pathology: Blood and Bone Marrow (2nd ed.). Philadelphia: Elsevier.
10. Karner KH (). Pyruvate Kinase Deficiency. In Foucar K (Ed.), Diagnostic Pathology: Blood and Bone Marrow (2nd ed.). Philadelphia: Elsevier.
11. Karner KH (). Acquired Red Cell Aplasia. In Foucar K (Ed.), Diagnostic Pathology: Blood and Bone Marrow (2nd ed). Philadelphia: Elsevier.
12. Karner KH (). Thrombocytic Thrombocytopenic Purpura. In Foucar K (Ed.), Diagnostic Pathology: Blood and Bone Marrow (2nd ed.). Philadelphia: Elsevier.
13. Karner KH (). Immune-Mediated Thrombocytopenia. In Foucar K (Ed.), Diagnostic Pathology: Blood and Bone Marrow (2nd ed.). Philadelphia: Elsevier.
14. Karner KH (). Parvovirus-Induced Red Cell Aplasia. In Foucar K (Ed.), Diagnostic Pathology: Blood and Bone Marrow (2nd ed.). Philadelphia: Elsevier.
15. Karner KH (). Chronic Myelomonocytic Leukemia. In Vasef MA, Auerbach A, Czuchlewski DR, Bocklage T, Chabot-Richards D, Aguilera N, Karner KH (Eds.), Diagnostic Pathology: Molecular Oncology. Philadelphia, PA: Elsevier.
16. Karner KH (). Lymphoma-Associated Chromosomal Translocations. In Vasef MA, Auerbach A, Czuchlewski DR, Bocklage T, Chabot-Richards D, Aguilera N, Karner KH (Eds.), Diagnostic Pathology: Molecular Oncology. Philadelphia, PA: Elsevier.
17. Karner KH (). B-Lymphoblastic Leukemia/Lymphoma With Recurrent Genetic Abnormalities. In Vasef MA, Auerbach A, Czuchlewski DR, Bocklage T, Chabot-Richards D, Aguilera N, Karner KH (Eds.), Diagnostic Pathology: Molecular Oncology. Philadelphia, PA: Elsevier.
18. Karner KH (). Refractory Cytopenia with Multilineage Dysplasia. In Vasef MA, Auerbach A, Czuchlewski DR, Bocklage T, Chabot-Richards D, Aguilera N, Karner KH (Eds.), Diagnostic Pathology: Molecular Oncology. Philadelphia, PA: Elsevier.
19. Karner KH (). Acute Myeloid Leukemia, NOS. In Vasef MA, Auerbach A, Czuchlewski DR, Bocklage T, Chabot-Richards D, Aguilera N, Karner KH (Eds.), Diagnostic Pathology: Molecular Oncology. Philadelphia, PA: Elsevier.
20. Karner KH (). Myelodysplastic Syndrome, Unclassifiable. In Vasef MA, Auerbach A, Czuchlewski DR, Bocklage T, Chabot-Richards D, Aguilera N, Karner KH (Eds.), Diagnostic Pathology: Molecular Oncology. Philadelphia, PA: Elsevier.
21. Karner KH (). Refraactory Cytopenia with Unilineage Dysplasia. In Vasef MA, Auerbach A, Czuchlewski DR, Bocklage T, Chabot-Richards D, Aguilera N, Karner KH (Eds.), Diagnostic Pathology: Molecular Oncology. Philadelphia, PA: Elsevier.
22. Karner KH (). FISH for ERBB2 (HER2) Gene Amplifications. In Vasef MA, Auerbach A, Czuchlewski DR, Bocklage T, Chabot-Richards D, Aguilera N, Karner KH (Eds.), Diagnostic Pathology: Molecular Oncology. Philadelphia, PA: Elsevier.
23. Karner KH (). Reverse Transcription PCR for Other Myeloid Leukemia Transcripts. In Vasef MA, Auerbach A, Czuchlewski DR, Bocklage T, Chabot-Richards D, Aguilera N, Karner KH (Eds.), Diagnostic Pathology: Molecular Oncology. Philadelphia, PA: Elsevier.
24. Hunt K (). Parvovirus-induced Red Cell Aplasia. In Foucar K, Zhang QY, Wilson C, Czuchlewski D, Vasef M, Reichard K, Hunt K (Eds.), Diagnostic Pathology: Blood & Bone Marrow. Salt Lake City, UT: Amirsys Publishing.
25. Hunt K (). Sickle Cell Anemia. In Foucar K, Zhang QY, Wilson C, Czuchlewski D, Vasef M, Reichard K, Hunt K (Eds.), Diagnostic Pathology: Blood & Bone Marrow. Salt Lake City, UT: Amirsys Publishing.
26. Hunt K (). Pyruvate Kinase Deficiency. In Foucar K, Zhang QY, Wilson C, Czuchlewski D, Vasef M, Reichard K, Hunt K (Eds.), Diagnostic Pathology: Blood & Bone Marrow. Salt Lake City, UT: Amirsys Publishing.
27. Hunt KE, Chabot-Richards D (). Hematologic Manifestations of Collagen Vascular Disorders. In Foucar K, Zhang QY, Wilson C, Czuchlewski D, Vasef M, Reichard K, Hunt K (Eds.), Diagnostic Pathology: Blood & Bone Marrow. Salt Lake City, UT: Amirsys Publishing.
28. Hunt KE, Chabot-Richards D (). Thrombotic Thrombocytopenic Purpura. In Foucar K, Zhang QY, Wilson C, Czuchlewski D, Vasef M, Reichard K, Hunt K (Eds.), Diagnostic Pathology: Blood & Bone Marrow. Salt Lake City, UT: Amirsys Publishing.
29. Hunt KE, Ruobing Xiao (). Thrombocytosis. In Foucar K, Zhang QY, Wilson C, Czuchlewski D, Vasef M, Reichard K, Hunt K (Eds.), Diagnostic Pathology: Blood & Bone Marrow. Salt Lake City, UT: Amirsys Publishing.
30. Hunt KE, Xiao (). Acute Monoblastic and Monocytic Leukemia. In Foucar K, Zhang QY, Wilson C, Czuchlewski D, Vasef M, Reichard K, Hunt K (Eds.), Diagnostic Pathology: Blood & Bone Marrow. Salt Lake City, UT: Amirsys Publishing.
31. Hunt KE, Chabot-Richards D (). Acute Erythroid Leukemia. In Foucar K, Zhang QY, Wilson C, Czuchlewski D, Vasef M, Reichard K, Hunt K (Eds.), Diagnostic Pathology: Blood & Bone Marrow. Salt Lake City, UT: Amirsys Publishing.
32. Hunt K (). Immune-Mediated Thrombocytopenia. In Foucar K, Zhang QY, Wilson C, Czuchlewski D, Vasef M, Reichard K, Hunt K (Eds.), Diagnostic Pathology: Blood & Bone Marrow. Salt Lake City, UT: Amirsys Publishing.
33. Hunt K (). Megaloblastic Anemia. In Foucar K, Zhang QY, Wilson C, Czuchlewski D, Vasef M, Reichard K, Hunt K (Eds.), Diagnostic Pathology: Blood & Bone Marrow. Salt Lake City, UT: Amirsys Publishing.
34. Hunt K (). Paroxysmal Nocturnal Hemoglobinuria. In Foucar K, Zhang QY, Wilson C, Czuchlewski D, Vasef M, Reichard K, Hunt K (Eds.), Diagnostic Pathology: Blood & Bone Marrow. Salt Lake City, UT: Amirsys Publishing.
35. Hunt K (). Acquired Red Cell Aplasia. In Foucar K, Zhang QY, Wilson C, Czuchlewski D, Vasef M, Reichard K, Hunt K (Eds.), Diagnostic Pathology: Blood & Bone Marrow. Salt Lake City, UT: Amirsys Publishing.
36. Hunt K (). Thalassemia. In Foucar K, Zhang QY, Wilson C, Czuchlewski D, Vasef M, Reichard K, Hunt K (Eds.), Diagnostic Pathology: Blood & Bone Marrow. Salt Lake City, UT: Amirsys Publishing.
37. Hunt K (). Hemolytic Uremic Syndrome. In Foucar K, Zhang QY, Wilson C, Czuchlewski D, Vasef M, Reichard K, Hunt K (Eds.), Diagnostic Pathology: Blood & Bone Marrow. Salt Lake City, UT: Amirsys Publishing.

Case Report

1. Moser KA, George TI, Karner KH (). Unexpected diagnosis of indolent systemic mastocytosis through evaluation of next generation sequencing data. CAP Today.

Abstract

1. Pac L, Clayton A, Karner K, Patel J (). Pathogenic RUNX1 variants frequently co-occur with mutations in genes regulating chromatin or RNA splicing in a large cohort of myeloid neoplasms [Abstract]. Mod Pathol, 32, 112.
2. Richardson A, White T, Karner K, Patel J (). Co-occurence of driver mutations in myeloid neoplasm [Abstract]. Mod Pathol, 32, 124.
3. Craig R, Patel J, Karner K (). Characterization of MPL mutations in myeloid malignancies [Abstract]. Mod Pathol, 32, 29.
4. Hunt KE, Gale JM, Reichard KK, Vasef MA (). Determination of Immunoglobulin Heavy Chain Variable (IgHV) Somatic Hypermutation Status on Fresh and Paraffin Embedded Tissue: A Reliable Alternative to Flow Cytometric Analysis of ZAP-70. Poster presentation at Association for Molecular Pathology Annual Meeting, Dallas, TX [Abstract]. J Mol Diagn, 10(6), 577.
5. Hunt KE, Gale JM, Reichard KK and Vasef MA (). Determination of immunoglobulin heavy chain variable (IgHV) somatic hypermutation status on fresh and paraffin embedded tissue: A reliable alternative to flow cytometric analysis of ZAP-70 [Abstract]. J Mol Diagn, 10(6), 577.
6. Hunt KE, Hall B, Reichard KK (). Translocations involving MUM1 are rare in diffuse large B-cell lymphoma, including the non-germinal center subtype. Poster presentation at American Society for Clinical Pathology Annual Meeting, Baltimore, MD [Abstract]. American Journal of Clinical Pathology, 130, 652.
7. Hunt KE, Hall B and Reichard KK (). Translocations involving MUM1 are rare in diffuse large B-cell lymphoma, including the non-germinal center subtype [Abstract]. Americal Journal of Clinical Pathology, 130, 652.
8. Hunt KE, Crookston KP (). The hemostatic agent QuikClot activates coagulation directly via the contact pathway [Abstract]. Transfusion, 43(9s), 1a-130a.
9. Hunt KE, Crookston KP (). The hemostatic agent QuikClot activates coagulation directly via the contact pathway. Oral presentation at American Association of Blood Banks Annual Meeting, San Diego, CA [Abstract]. Transfusion, 43(9s), 1-130a.

Video/Film/CD/Web/Podcast

1. Karner KH (). NGS Panels: How Do They Help in Diagnosing Myeloid Neoplasms? [Web]. Salt Lake City, UT: ARUP Laboratories. Available: https://www.aruplab.com/news/02-12-2019/NGS-myeloid-neoplasms-malignancies-Karner.